Yumetra
Plant-Based Antiviral Ingredients for Functional Foods and Oral Wellness
Company Overview
Snapshot
Founded in April 2021 by Gilad Agmon and Eli Pinthus, Yumetra operates with 1–10 employees. The company has secured funding across two rounds, including a Pre-Seed round in March 2026 with participation from Fresh Start.
Business overview
Yumetra develops functional food products and plant-derived bioactives aimed at supporting oral health and proactive wellness. The company's core technology is Cinnovir, a patented botanical extract produced through advanced fractionation and formulation. By integrating these bioactives into everyday food formats, Yumetra addresses health at the oral environment without requiring significant changes in consumer behavior, serving markets within the Agriculture & Food Technologies sector, specifically focusing on Novel Food & Ingredients and Food Processing.
Strategic signal
In April 2026, Yumetra was featured in a Maariv article discussing strategic innovation collaborations by the Wingate Institute. This highlights the company's engagement in broader innovation ecosystems, signaling potential for strategic partnerships and validation of its novel approach to plant-based bioactives within the functional food industry.
Log in to access full profile ›Company Intelligence Q&A
- When was Yumetra founded?
- Yumetra was founded in April 2021.
- Which investors participated in Yumetra's Pre-Seed funding round?
- In March 2026, Yumetra secured Pre-Seed funding with participation from Fresh Start.
- Has Yumetra received any grants?
- In January 2025, Yumetra received a grant from the Israel Innovation Authority.
- What is Yumetra's primary product?
- Yumetra's primary products include Cinnovir Functional Candy and Cinnovir Active Ingredient, based on its patented botanical extract.
- What is the strategic significance of the Wingate Institute's collaborations mentioned in April 2026?
- The Maariv article in April 2026 highlighted Yumetra's involvement in strategic innovation collaborations by the Wingate Institute, indicating the company's integration into broader R&D initiatives and potential for future partnerships in the functional food space.